Journal of Isfahan Medical School

Journal of Isfahan Medical School

Review Addressing the HLADR3 and HLA-DR4 Haplotypes in the Susceptibility of Type 1 Diabetes: A Bioinformatic Analysis View Full-Text

Document Type : Review Article

Authors
Mansoureh Azadeh 1
Hamidreza Roshani Dastgerdi 1
Pardis Karimian 1
Sayedeh Zahra Shirdeli 1
Marjan Zareian Jahromi 2
1 Zist Fanavari Novin Biotechnology Institute, Iran Technical and Vocational Training Organization, Isfahan, Iran
2 Isfahan University of Medical Sciences, Isfahan, Iran
10.48305/jims.v43.i815.0527
Abstract
Background: Type 1 diabetes (T1D) is a multifactorial autoimmune disease characterized immune-mediated destruction of pancreatic β-cells and influenced by a combination of genetic and environmental factors. Among the genetic factors, the human leukocyte antigen (HLA) region, especially the HLA-DR3 and HLA-DR4 haplotypes, plays a key role in increasing disease susceptibility. These haplotypes are thought to mediate increased auto-antigen presentation to autoreactive CD4⁺ T-helper cells leading to β-cell destruction.
Methods: This review study examines the bioinformatic perspective of SNPs and ncRNAs related to the HLA region in T1D and analyzes studies published between 2015 and 2025. The dbSNP and ClinVar databases were used to identify four key SNPs: rs3135002, rs9260151, rs9271365, and rs9273364, all located within or near the major histocompatibility complex (MHC) class II region. Although their clinical significance is not definitively confirmed in ClinVar, data from GWAS suggest their potential association with T1D. Analysis using the miRWalk tool indicated that hsa-miR-5585-3p may target the HLA-DQA1 gene, and results from lncRRIsearch suggested that lncRNA RP11-573D15.8-018 may also interact with this same gene.
Findings: Although their clinical significance is not definitively confirmed in ClinVar, data from GWAS suggest their potential association with T1D. Analysis using the miRWalk tool indicated that hsa-miR-5585-3p may target the HLA-DQA1 gene, and results from lncRRIsearch suggested that lncRNA RP11-573D15.8-018 may also interact with this same gene.
Conclusion: The present review focuses on the importance of HLA-DR3 and HLA-DR4 haplotypes in increasing susceptibility to type 1 diabetes and points to the potential regulatory effects of specific SNPs, microRNAs, and lncRNAs in HLA-DQA1 gene expression. These results underscore the utility of bioinformatics for revealing molecular mechanisms of T1D and possibly for designing personalized diagnostic and therapeutic approaches.

Highlights

Mansoureh Azadeh: Google Scholar 

Marjan Zareian Jahromi: Google Scholar

Keywords
Type 1 diabetes
HLA-DR3
HLA-DR4
MHC class II
LncRNA
Subjects
  1. Cheung YH, Watkinson J, Anastassiou D. Conditional meta-analysis stratifying on detailed HLA genotypes identifies a novel type 1 diabetes locus around TCF19 in the MHC. Hum Genet 2011; 129(2): 161–76.
  2. Pociot F, Akolkar B, Concannon P, Erlich HA, Julier C, Morahan G, et al. Genetics of Type 1 Diabetes: What’s Next? Diabetes 2010; 59(7): 1561–71.
  3. Sticht J, Álvaro-Benito M, Konigorski S. Type 1 Diabetes and the HLA Region: Genetic Association Besides Classical HLA Class II Genes. Front Genet 2021; 12: 683946.
  4. Noble JA, Valdes AM. Genetics of the HLA Region in the Prediction of Type 1 Diabetes. Curr Diab Rep 2011; 11(6): 533–42.
  5. Telang G, Mishra S, Sureshbabu A, Chiloo S, Joshi S, Thyagarajan S. HLA Class I and II genes: A key factor for type one diabetes susceptibility. Gene Reports 2025; 39: 102183.
  6. Gearty S V, Dündar F, Zumbo P, Espinosa-Carrasco G, Shakiba M, Sanchez-Rivera FJ, et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 2022; 602(7895): 156–61.
  7. Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3’-untranslated region of ErbB4 in breast cancer. Mol Med Rep 2016; 13(5): 4494–8.
  8. Ebrahimi Ghahnavieh L, Tabatabaeian H, Ebrahimi Ghahnavieh Z, Honardoost MA, Azadeh M, Moazeni Bistgani M, et al. Fluctuating expression of miR-584 in primary and high-grade gastric cancer. BMC Cancer 2020; 20(1): 621.
  9. Ezzati E, Mosadeghi S, Akbarinia A, Horriat S, Rezaei M, Azadeh M. Linc00520 promotes breast cancer development by low expression as a tumor suppressor and prognostic biomarker by regulating the esr2 expression level: integrated systems biology bioinformatics and experimental analyses. 2022. Available from: https://assets-eu.researchsquare.com/files/rs-1944462/v1/8e04cdeb-825d-44cd-9851-70a466f1bb5b.pdf?c=1660154030
  10. Michalek DA, Tern C, Zhou W, Robertson CC, Farber E, Campolieto P, et al. A multi-ancestry genome-wide association study in type 1 diabetes. Hum Mol Genet 2024; 33(11): 958–68.
  11. Azadeh M, Salehzadeh A, Ghaedi K, Talesh Sasani S. NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis. Genes Environ 2022; 44(1): 16.
  12. Azadeh M, Salehzadeh A, Ghaedi K, Sasani ST. Decreased expression level of long non-coding RNA CCAT1, was observed in breast cancer tissue of an Isfahanian population (Iran). Gene Reports 2021; 23: 101154.
  13. Lipponen K, Gombos Z, Kiviniemi M, Siljander H, Lempainen J, Hermann R, et al. Effect of HLA Class I and Class II Alleles on Progression From Autoantibody Positivity to Overt Type 1 Diabetes in Children With Risk-Associated Class II Genotypes. Diabetes 2010; 59(12): 3253–6.
  14. Lee HS, Hwang JS. Genetic aspects of type 1 diabetes. Ann Pediatr Endocrinol Metab 2019; 24(3): 143–8.
  15. de Filette JMK, Pen JJ, Decoster L, Vissers T, Bravenboer B, van der Auwera BJ, et al. Immune checkpoint inhibitors and type 1 diabetes mellitus: a case report and systematic review. Eur J Endocrinol 2019; 181(3): 363–74.
  16. Hajjej A, Almawi WY, Stayoussef M, Arnaiz-Villena A, Hattab L, Hmida S. Association of HLA-DRB1 and -DQB1 alleles with type 1 (autoimmune) diabetes in African Arabs: systematic review and meta-analysis. Immunol Invest 2019; 48(2): 130–46.
  17. Robino A, Bevilacqua E, Aldegheri L, Conti A, Bazzo V, Tornese G, et al. Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset. Front Immunol 2024; 15: 1427349.
  18. Gomes KFB, Santos AS, Semzezem C, Correia MR, Brito LA, Ruiz MO, et al. The influence of population stratification on genetic markers associated with type 1 diabetes. Sci Rep 2017; 7(1): 43513.
  19. Pociot F, Lernmark Å. Genetic risk factors for type 1 diabetes. Lancet. 2016;387(10035):2331–9.
  20. Ning P, Mu X, Yang X, Li T, Xu Y. Prevalence of restless legs syndrome in people with diabetes mellitus: A pooling analysis of observational studies. EClinicalMedicine 2022; 46: 101357.
  21. Roshandel D, Gubitosi-Klug R, Bull SB, Canty AJ, Pezzolesi MG, King GL, et al. Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes. Diabetologia 2018; 61(5): 1098–111.
  22. Michalek DA, Tern C, Zhou W, Robertson CC, Farber E, Campolieto P, et al. A multi-ancestry genome-wide association study in type 1 diabetes. Hum Mol Genet 2024; 33(11): 958–68.
Journal of Isfahan Medical School
Volume 43, Issue 815
3rd Week, July
July and August 2025
Pages 527-532

  • Receive Date 03 June 2025
  • Accept Date 12 August 2025